Latest filing published 11 Sept 2023 for Faeth Therapeutics, Inc., €13k.
Insider track record
No signal scores available.
Patrick Stephen Gallagher: trading record in brief
This profile gathers the share dealings of Patrick Stephen Gallagher in Faeth Therapeutics, Inc. We count 5 filings, every one of them for a trade on 15 February 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 11 September 2023, reports a share grant of €13k in Faeth Therapeutics, Inc. Typically, a trade is published a median of 42 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Patrick Stephen Gallagher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,383 shares@ US$1.50100.0% of flowCommon StockSEC:0001209191-23-048968:0
- 14,200 shares0Common StockSEC:0001209191-23-021540:1
- 29,313 shares0Common StockSEC:0001209191-23-021540:0
- 14,200 shares0Common StockSEC:0001209191-23-010734:1
- 29,313 shares0Common StockSEC:0001209191-23-010734:0
5 of 5 declarations
